Inofolic Combi HP is a dietary product based on myo-inositol and d-chiro-inositol in a physiological ratio of 40:1, folic acid and alpha-lactalbumin.
The advanced formulation with alphalactalbumin increases the product's effectiveness by up to 95%.
The unique combination of inositol in INOFOLIC® Combi HP in an ideal ratio provides better metabolic effects (insulin resistance, hyperinsulinemia, metabolic syndrome), has a positive effect on the regulation of PCOS signs and symptoms, and has a positive effect on fertility. The ratio of inositol 40:1 is patent protected and covered by a large number of clinical studies where the effectiveness for the mentioned conditions has been confirmed. The preparation is ideal for people who are slightly overweight (BMI≥25) and for obese people (BMI≥30).
The softgel capsule, as the most prestigious oral pharmaceutical form, ensures the best bioavailability of active components, achieving a 3x greater effect of myo- and d-chiro-inositol compared to the same dose in powder form.
It is recommended for the treatment of: polycystic ovary syndrome (PCOS), insulin resistance - prediabetes, type II diabetes, in protocols of controlled ovarian hyperstimulation.
